Pimavanserin Resubmitted to FDA; APA's New President Elect; Bipolar Market Slowing - MedPage Today

Submitted by Anonymous (not verified) on Wed, 02/23/2022 - 20:30

Pimavanserin Resubmitted to FDA; APA's New President Elect; Bipolar Market Slowing  MedPage Today